Maryland Cancer Action Center

ANNAPOLIS, MD – February 27, 2024 – Tomorrow, the Maryland Senate Finance Committee will consider Senate Bill 595, which seeks to create more predictability for patients facing high out-of-pocket expenses for lifesaving medication. The following day, February 29, the House Health and Government Operations Committee will hold a hearing

ANNAPOLIS, MD – FEBRUARY 12, 2024 – Earlier tonight, American Cancer Society Cancer Action Network (ACS CAN) volunteers rallied at the Maryland State House as a part of their annual Cancer Action Day, urging lawmakers to support two proposals—the first, is a call to lawmakers to support an investment

ANNAPOLIS, MD – DECEMBER 20, 2023 – On January 1, 2024, Marylanders will gain access to biomarker testing when Chapter 322 of the Laws of 2023 takes effect for private insurers. The legislation, which requires coverage of biomarker testing when supported by scientific and medical evidence, received near-unanimous support

ANNAPOLIS, MD – MAY 3, 2023 – Today, Gov. Wes Moore will be signing HB 1217 / SB 805—among many other bills—into law. This legislation will increase insurance coverage for biomarker testing, making this form of precision medicine available to more Marylanders. The signing ceremony will take place today at